|
Sunday, 08/01/2010
|
American Community Survey Sample Size Research
Steven Hefter, U.S. Census Bureau
2:05 PM
|
Eliciting and Incorporating Priors on Effect Size Distributions in Genomewide Association Studies
Ju-Hyun Park, National Cancer Institute; Nilanjan Chatterjee, National Cancer Institute
2:05 PM
|
A Comparison of Several Methods for Analyzing Data from Thorough QT Studies
Hong Tian, Johnson & Johnson; Wenqian Qiao, Rutgers University; Jaya Natarajan, Johnson & Johnson
4:25 PM
|
An Improved Variance-Smoothing Method for Testing Differential Expression in Small-Sample-Size Affymetrix Oligonucleotide Microarrays
Parul Gulati, The Ohio State University; David Jarjoura, The Ohio State University; Soledad Fernandez, The Ohio State University; Lianbo Yu, The Ohio State University; Michael Pennell, The Ohio State University
4:50 PM
|
|
Monday, 08/02/2010
|
Establishing Sample Size in Clinical Trials Having Multiple Hypotheses
Alan Barry Davis, Pharmanet Development Group, Inc.; Mary M. Poole, Pharmanet Development Group, Inc.; Young Kim, Pharmanet Development Group, Inc.
|
Adjusted Cumulative Distribution Function and Effect Size Methods for Stratified Two-Sample Comparisons
Kelly H. Zou, Pfizer Inc.; Martin O. Carlsson, Pfizer Inc.; Ching-Ray Yu, Pfizer Inc.
|
The Impact of Small Cluster Size on Multilevel Models: A Monte Carlo Examination of Two-Level Models with Binary and Continuous Predictors
Bethany A. Bell, University of South Carolina; Grant B. Morgan, University of South Carolina; Jeffrey D. Kromrey, University of South Florida; John M. Ferron, University of South Florida
|
Spline Models for the Population Total from PPS Samples: The Precision Gain from Knowing the Sizes of Nonsampled Units
Sahar Z. Zangeneh, University of Michigan; Roderick Joseph Little, University of Michigan
|
Interim Analysis: Does It Really Save Time?
Jin-Yi Chen, Merck Research Laboratories
|
A Model for Multilevel Clustered Data with Informative Cluster Size Using Poisson Distribution
Ana-Maria Iosif, University of California, Davis; Allan Sampson, University of Pittsburgh
|
Sample Size and Power Considerations for Futility Trial Design: Buying Power vs. Spending Beta
Thomas Dobbins, Merck & Co., Inc.
8:50 AM
|
Sample-Size Estimation for Detecting Trends in Repeated Surveys
Mark C. Otto, U.S. Fish and Wildlife Service
9:20 AM
|
Pairwise Variable Selection for Classification
Xingye Qiao, The University of North Carolina at Chapel Hill; Yufeng Liu, The University of North Carolina at Chapel Hill; J. S. Marron, The University of North Carolina at Chapel Hill
9:50 AM
|
Achieving the Benefits of Both an Internal Pilot and Interim Analysis in Small Samples
John A. Kairalla, University of Florida; Keith E. Muller, University of Florida; Christopher S. Coffey, The University of Iowa
10:35 AM
|
Sample Size Requirement in Clustered Matched-Pair Design for Noninferiority Test
Jun-mo Nam, National Cancer Institute
11:20 AM
|
Adaptive Design for Sample Size Re-estimation in a Medical Device Trial of Spinal Cord Stimulation
Nitzan Mekel-Bobrov, Boston Scientific Corporation
2:05 PM
|
PCA Consistency for High-Dimension, Low Sample Size Context
Sungkyu Jung, The University of North Carolina at Chapel Hill; J. S. Marron, The University of North Carolina at Chapel Hill
2:20 PM
|
Adaptive Sample Size Re-estimation When Interim Results Are Promising
Cyrus R. Mehta, Cytel Inc.
2:25 PM
|
Sample Size Estimates for Correlated Data in a Device Trial
Xiaolong Shih, Boston Scientific Corporation
2:25 PM
|
An Adaptive Noninferiority Study
Pilar Lim, Johnson & Johnson; Qing Liu, Johnson & Johnson; Rosanne Lane, Johnson & Johnson; Barry Schwab, Johnson & Johnson; Allan Sampson, University of Pittsburgh
2:45 PM
|
Sample Size Consideration on Search for Correlative Models from High-Throughput Screening Data
Xian-Jin Xie, The University of Texas Southwestern Medical Center at Dallas; Yijie Liao, Southern Methodist University; Jason Yan, The University of Texas Southwestern Medical Center at Dallas
2:50 PM
|
|
Tuesday, 08/03/2010
|
Sample-Size Estimation for the Interaction Between Two Binary Covariates in a Cox Proportional Hazard Regression Model
Abu Minhajuddin, The University of Texas Southwestern Medical Center at Dallas; Xian-Jin Xie, The University of Texas Southwestern Medical Center at Dallas
|
Effect Size in Mediation Analysis
Elizabeth Newton, Institute for Aging Research
9:05 AM
|
Sample Size Re-estimation in Crossover Trials
Adina Soaita, Pfizer Inc.; Byron Jones, Pfizer Inc.; Jerry J. Weaver, Pfizer Inc.
10:35 AM
|
Sample-Size Calculation for Time-to-Event Outcome with Treatment Lag Effect
Yulei Zhang, Columbia University; Tai-Tsang Chen, Bristol-Myers Squibb/Columbia University
11:20 AM
|
Sample-Size Calculation for the Andersen-Gill Model in the Presence of Subject Heterogeneity in the Baseline Risk
Antje Jahn-Eimermacher, University of Mainz; Katharina Ingel, University of Mainz
2:20 PM
|
Asymptotically Similar Unit Root Tests in the Presence of Autocorrelated Errors
Michalis Stamatogiannis, University of Groningen
2:35 PM
|
Sample Size Determination in Two-Sided Distribution-Free Treatment vs. Control Multiple Comparisons
Chunpeng Fan, sanofi-aventis; Donghui Zhang, sanofi-aventis
2:50 PM
|
Estimating the Size of the Nonimmigrant Population Residing in the United States
Bryan C. Baker, U.S. Department of Homeland Security
3:05 PM
|
High-Dimension, Low-Sample Size Mathematical Statistics
J. S. Marron, The University of North Carolina at Chapel Hill
3:20 PM
|
|
Wednesday, 08/04/2010
|
Calculation of Sample Size for Testing the Performance of Disease Risk Prediction Models from Survival Analysis Based on Harrell's C Discrimination Index
Ching-Yu Huang, National Health Research Institutes, Taiwan; Hsing-Yi Chang, National Health Research Institutes, Taiwan; Wen-ling Liu, National Health Research Institutes, Taiwan
|
Threshold-Free Cluster Enhancement (TFCE): Improving Power and Stability of Cluster Size Inference in Brain Imaging
Thomas E. Nichols, University of Warwick
8:35 AM
|
Probability-Proportional-to-Size Sampling from a Rare Population
Jens Olofsson, Örebro University
8:50 AM
|
The Bayesian Hierarchical Model for Estimating the Size of HIV At-Risk Populations in Bangladesh
Le Bao, University of Washington; Adrian E. Raftery, University of Washington; Amala Reddy, UNAIDS Regional Support Team Asia-Pacific
9:20 AM
|
Use of CUSUM Control Charts When Population Size Changes Over Time
J. Brooke Marshall, Merck Research Laboratories; Dan J. Spitzner, University of Virginia
9:20 AM
|
Meta-Analysis of Survey Data to Estimate the Size of the Population of Men Who Have Sex with Men for Calculating HIV Rates
Christopher H. Johnson, CDC; David Purcell, CDC; Amy Lansky, CDC; Joseph Prejean, CDC; Paul Denning, CDC; Nicole Crepaz, CDC; Zaneta Gaul, CDC; Renee Stein, CDC; Zaneta Gaul, CDC
9:35 AM
|
Statistical Inference in Factor Analysis for High-Dimension, Low-Sample-Size Data
Miguel Marino, Harvard University/Dana-Farber Cancer Institute; Yi Li, Harvard University/Dana-Farber Cancer Institute
10:50 AM
|
High-Dimension, Low-Sample-Size Asymptotics Using Deterministic Geometric Structure of Stochastic Data: Application to an Extension of SVM for Data on Manifolds
Suman Kumar Sen, Novartis Pharmaceuticals Corporation; J. S. Marron, The University of North Carolina at Chapel Hill; Mark Foskey, The University of North Carolina at Chapel Hill; Sarang Joshi, The University of Utah
2:20 PM
|
Statistical Challenges and Issues Related to Multiregion Trials
Sibabrata Banerjee, Merck & Co., Inc.; Lucy Shneyer, Merck & Co., Inc.
3:05 PM
|
|
Thursday, 08/05/2010
|
A Relative Measure of Effect Size for Paired Data Generalizing the Wilcoxon Matched-Pairs Signed-Ranks Test Statistic
Robert Gordon Newcombe, Cardiff University
8:35 AM
|
Sample Size Determination for Two-Stage Equivalence Test
Mi-Chia Ma, National Cheng Kung University; Shang-Bo Ye, National Cheng Kung University
8:35 AM
|
Sample Size Re-estimation for a Time-to-event Endpoint Based on Stratified Analysis
Liang Chen, Pfizer Inc.
8:50 AM
|
Some Recent Advances on Quaternary-Code Designs
Frederick Kin Hing Phoa, Academia Sinica
9:05 AM
|
Sample Size and Power for Truncated Bivariate Normal Distribution
Sourav Santra, Takeda Pharmaceutical Company Limited
9:05 AM
|
Exact Sample Size Calculations for Noninferiority Trials with Binomial Endpoints
Cyrus R. Mehta, Cytel Inc.; Lingyun Liu, Cytel Inc.; Pralay Senchaudhuri, Cytel Inc.
9:20 AM
|
Adaptive Sample Size Re-Estimation in Oncology Trials
Pralay Mukhopadhyay, Bristol-Myers Squibb
9:20 AM
|
The Proportional Odds Model with an Anchor
David Oakes, University of Rochester
9:35 AM
|
Power and Sample Size Calculations for Drug Exposure Registries Using Exact Methods
Paul Schuette, FDA; Eugenio Andraca-Carrera, FDA; Matthew Jackson, FDA; Benjamin Neustifter, FDA
9:35 AM
|
Sample Size Planning to Obtain Narrow Confidence Intervals for the RMSEA
Ken Kelley, University of Notre Dame; Keke Lai, University of Notre Dame
10:50 AM
|
A Simulation Study on the Effects of Increasing the Number of Capture Periods in Closed Population Capture-Recapture Models with Heterogeneity
Jose Sanqui, Appalachian State University; Ross Gosky, Appalachian State University
10:50 AM
|
Design and Trial Operational Considerations for a Phase II Two-Stage Adaptive Trial
Weili He, Merck & Co., Inc.; Madhuja Mallick, Merck & Co., Inc.; Yevgen Tymofyeyev, Merck & Co., Inc.; James A. Bolognese, Cytel Inc.
10:55 AM
|
A Simulation Study to Evaluate Sample Size and Power for a Trial to Develop a Prediction Rule Using Machine Learning Methods
Radha Railkar, Merck & Co., Inc.; Matthew Wiener, Merck & Co., Inc.; Leonidas Carayannopoulos, Merck & Co., Inc.
11:20 AM
|
A Rare Event Model for Growth Dynamics
Dodi Devianto, Andalas University
11:20 AM
|
|